Dai Lixia, He Jian, Miao Xiaolou, Guo Xiao, Shang Xiaofei, Wang Weiwei, Li Bing, Wang Yu, Pan Hu, Zhang Jiyu
Key Laboratory of New Animal Drug Project, Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Tibetan Medical College of Qinghai University, Xining, China.
Front Pharmacol. 2021 Feb 10;12:599778. doi: 10.3389/fphar.2021.599778. eCollection 2021.
przewalskii Maxim. is an evergreen shrub that is used as a traditional medicine in China. However, the modern pharmacology and the chemical components of this plant has not been studied. In this paper, we aimed to investigate the antifungal, anti-inflammatory and antioxidant activities and underlying mechanism of its aqueous and ethanol extracts, and analyze their chemical composition and active compounds of . The antifungal activity was determined , and anti-inflammatory and antioxidant activities and underlying mechanism of its aqueous and ethanol extracts were evaluated and in RAW 264.7 cells. The chemical composition were analyzed using UPLC-ESI-Q-TOF/MS, and the contents of six compounds were determined via HPLC. Both extracts of showed promising anti-inflammatory activity ; decreased the production of four inflammatory cytokines, namely, nitric oxide, IL-1β, IL-6 and TNF-, in RAW 264.7 cells induced by lipopolysaccharide; and exhibited weak cytotoxicity. The extracts significantly scavenged DPPH radicals, superoxide radicals and hydroxyl radicals to exert antioxidant effects . The two extracts also exhibited cellular antioxidant activity by increasing superoxide dismutase and CAT activities and decreasing malondialdehyde content in RAW 264.7 cells induced by LPS. However, the antifungal activity of the two extracts was weak. Nine flavonoids were identified by UPLC-ESI-Q-TOF/MS. Of these, six compounds were analyzed quantitatively, including avicularin, quercetin, azaleatin, astragalin and kaempferol, and five compounds (myricetin 3-O-galactoside, paeoniflorin, astragalin, azaleatin and kaempferol) were found in this species for the first time. These compounds demonstrated antioxidant activities that were similar to those of the extracts and were thought to be the active compounds in the extracts extracts presented promising anti-inflammatory and antioxidant activities. The extracts contained amounts of valuable flavonoids (8.98 mg/g fresh material) that were likely the active compounds in the extract contributing to the potential antioxidant activity. These results highlight the potential of as a source of natural antioxidant and anti-inflammatory agents for the pharmaceutical industry.
祁连圆柏是一种常绿灌木,在中国被用作传统药物。然而,该植物的现代药理学和化学成分尚未得到研究。在本文中,我们旨在研究其水提取物和乙醇提取物的抗真菌、抗炎和抗氧化活性及其潜在机制,并分析它们的化学成分和活性化合物。测定了抗真菌活性,并在RAW 264.7细胞中评估了水提取物和乙醇提取物的抗炎和抗氧化活性及其潜在机制。使用超高效液相色谱-电喷雾电离-四极杆飞行时间质谱(UPLC-ESI-Q-TOF/MS)分析化学成分,并通过高效液相色谱(HPLC)测定六种化合物的含量。两种提取物均显示出有前景的抗炎活性;降低了脂多糖诱导的RAW 264.7细胞中四种炎性细胞因子的产生,即一氧化氮、白细胞介素-1β、白细胞介素-6和肿瘤坏死因子-α;并且表现出较弱的细胞毒性。提取物显著清除二苯基苦味酰基自由基、超氧自由基和羟基自由基以发挥抗氧化作用。两种提取物还通过增加超氧化物歧化酶和过氧化氢酶活性以及降低脂多糖诱导的RAW 264.7细胞中的丙二醛含量来表现出细胞抗氧化活性。然而,两种提取物的抗真菌活性较弱。通过UPLC-ESI-Q-TOF/MS鉴定出九种黄酮类化合物。其中,对六种化合物进行了定量分析,包括扁蓄苷、槲皮素、杜鹃花素、黄芪苷和山奈酚,并且在该物种中首次发现了五种化合物(杨梅素3-O-半乳糖苷、芍药苷、黄芪苷、杜鹃花素和山奈酚)。这些化合物表现出与提取物相似的抗氧化活性,被认为是提取物中的活性化合物。提取物表现出有前景的抗炎和抗氧化活性。提取物含有大量有价值的黄酮类化合物(8.98毫克/克鲜物质),这些黄酮类化合物可能是提取物中有助于潜在抗氧化活性的活性化合物。这些结果突出了祁连圆柏作为制药行业天然抗氧化剂和抗炎剂来源的潜力。